ketorolac has been researched along with Pneumothorax, Primary Spontaneous in 2 studies
Ketorolac: A pyrrolizine carboxylic acid derivative structurally related to INDOMETHACIN. It is an NSAID and is used principally for its analgesic activity. (From Martindale The Extra Pharmacopoeia, 31st ed)
ketorolac : A racemate comprising equimolar amounts of (R)-(+)- and (S)-(-)-5-benzoyl-2,3-dihydro-1H-pyrrolizine-1-carboxylic acid. While only the (S)-(-) enantiomer is a COX1 and COX2 inhibitor, the (R)-(+) enantiomer exhibits potent analgesic activity. A non-steroidal anti-inflammatory drug, ketorolac is mainly used (generally as the tromethamine salt) for its potent analgesic properties in the short-term management of post-operative pain, and in eye drops to relieve the ocular itching associated with seasonal allergic conjunctivitis. It was withdrawn from the market in many countries in 1993 following association with haemorrhage and renal failure.
5-benzoyl-2,3-dihydro-1H-pyrrolizine-1-carboxylic acid : A member of the class of pyrrolizines that is 2,3-dihydro-1H-pyrrolizine which is substituted at positions 1 and 5 by carboxy and benzoyl groups, respectively.
| Excerpt | Relevance | Reference |
|---|---|---|
| "We sought to determine the effect of ketorolac on pediatric primary spontaneous pneumothorax recurrence after operation." | 7.88 | The use of perioperative ketorolac in the surgical treatment of pediatric spontaneous pneumothorax. ( Cairo, SB; Dorman, RM; Rothstein, DH; Vali, K; Ventro, G, 2018) |
| "Despite the intrinsic antiinflammatory properties of ketorolac, our data suggests that its use for patients undergoing pleurodesis for spontaneous pneumothorax does not detrimentally influence the outcomes of surgery." | 7.81 | Ketorolac does not reduce effectiveness of pleurodesis in pediatric patients with spontaneous pneumothorax. ( Bickler, SW; Davenport, KP; Fairbanks, T; Grabowski, J; Kling, K; Langness, S; Lizardo, RE, 2015) |
| "We sought to determine the effect of ketorolac on pediatric primary spontaneous pneumothorax recurrence after operation." | 3.88 | The use of perioperative ketorolac in the surgical treatment of pediatric spontaneous pneumothorax. ( Cairo, SB; Dorman, RM; Rothstein, DH; Vali, K; Ventro, G, 2018) |
| "Despite the intrinsic antiinflammatory properties of ketorolac, our data suggests that its use for patients undergoing pleurodesis for spontaneous pneumothorax does not detrimentally influence the outcomes of surgery." | 3.81 | Ketorolac does not reduce effectiveness of pleurodesis in pediatric patients with spontaneous pneumothorax. ( Bickler, SW; Davenport, KP; Fairbanks, T; Grabowski, J; Kling, K; Langness, S; Lizardo, RE, 2015) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dorman, RM | 1 |
| Ventro, G | 1 |
| Cairo, SB | 1 |
| Vali, K | 1 |
| Rothstein, DH | 1 |
| Lizardo, RE | 1 |
| Langness, S | 1 |
| Davenport, KP | 1 |
| Kling, K | 1 |
| Fairbanks, T | 1 |
| Bickler, SW | 1 |
| Grabowski, J | 1 |
2 other studies available for ketorolac and Pneumothorax, Primary Spontaneous
| Article | Year |
|---|---|
The use of perioperative ketorolac in the surgical treatment of pediatric spontaneous pneumothorax.
Topics: Adolescent; Anti-Inflammatory Agents, Non-Steroidal; Child; Female; Follow-Up Studies; Humans; Ketor | 2018 |
Ketorolac does not reduce effectiveness of pleurodesis in pediatric patients with spontaneous pneumothorax.
Topics: Adolescent; Anti-Inflammatory Agents, Non-Steroidal; Child; Combined Modality Therapy; Female; Human | 2015 |